Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)

被引：3

作者：

Bidet, Audrey ^{[1
]}

Quessada, Julie ^{[2
,3
]}

Cuccuini, Wendy ^{[4
]}

Decamp, Matthieu ^{[5
]}

Lafage-Pochitaloff, Marina ^{[2
]}

Luquet, Isabelle ^{[6
]}

Lefebvre, Christine ^{[7
]}

Tueur, Giulia ^{[8
]}

机构：

[1] CHU Bordeaux, Lab Hematol Biol, Ave Magellan, F-33600 Pessac, France

[2] Aix Marseille Univ, Hop Enfants Timone, Assistance Pub Hop Marseille APHM, Fac Med,Lab Cytogenet Hematol, F-13005 Marseille, France

[3] Aix Marseille Univ, CIML, CNRS, INSERM, F-13009 Marseille, France

[4] Hop St Louis, Assistance Publ Hop Paris AP HP, Lab Hematol, Paris, France

[5] CHU Caen Normandie, Serv Neurol, F-14000 Caen, France

[6] CHU Toulouse, Lab Hematol, Site IUCT O, Toulouse, France

[7] CHU Grenoble Alpes, Serv Hematol Biol, Unite Genet Hemopathies, Grenoble, France

[8] CHU Avicenne, AP HP, Lab Hematol, Bobigny, France

来源：

CURRENT RESEARCH IN TRANSLATIONAL MEDICINE | 2023年 / 71卷 / 04期

关键词：

Acute myeloid leukemia; Histiocytic/dendritic cell neoplasms; Cytogenetic abnormalities; Prognosis; ACUTE MEGAKARYOBLASTIC LEUKEMIA; CORE-BINDING-FACTOR; HEALTH-ORGANIZATION CLASSIFICATION; INDIVIDUAL PATIENT DATA; MONOSOMAL KARYOTYPE; COMPLEX KARYOTYPE; POOR-PROGNOSIS; ADULT PATIENTS; HIGH-RISK; AML;

D O I：

10.1016/j.retram.2023.103421

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Genetic data are becoming increasingly essential in the management of hematological neoplasms as shown by two classifications published in 2022: the 5th edition of the World Health Organization Classification of Hematolymphoid Tumours and the International Consensus Classification of Myeloid Neoplasms and Acute Leukemias. Genetic data are particularly important for acute myeloid leukemias (AMLs) because their boundaries with myelodysplastic neoplasms seem to be gradually blurring. The first objective of this review is to present the latest updates on the most common cytogenetic abnormalities in AMLs while highlighting the pitfalls and difficulties that can be encountered in the event of cryptic or difficult-to-detect karyotype abnormalities. The second objective is to enhance the role of cytogenetics among all the new technologies available in 2023 for the diagnosis and management of AML.

引用

页数：13

共 17 条

[1] Cytogenetics in the management of chronic lymphocytic leukemia: Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)
Nguyen-Khac, Florence
Balogh, Zsofia
Chauzeix, Jasmine
Veronese, Lauren
Chapiro, Elise
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[2] Cytogenetics in the management of hematologic neoplasms with germline predisposition: guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)
Gachard, Nathalie
Lafage-Pochitaloff, Marina
Quessada, Julie
Auger, Nathalie
Collonge-Ramee, Marie-Agnes
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[3] Cytogenetics in the management of bone marrow failure syndromes: Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)
Cuccuini, Wendy
Collonge-Rame, Marie-Agnes
Auger, Nathalie
Douet-Guilbert, Nathalie
Coster, Lucie
Lafage-Pochitaloff, Marina
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[4] Cytogenetics in the management of mature T-cell and NK-cell neoplasms: Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)
Gaillarda, Jean-Baptiste
Chapirob, Elise
Daudignond, Agnes
Nadale, Nathalie
Pentherf, Dominique
Chauzeixg, Jasmine
Nguyen-Khacb, Florence
Veroneseh, Lauren
Lefebvrej, Christine
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[5] Cytogenetics in the management of T-cell acute lymphoblastic leukemia (T-ALL): Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)
Bie, Jolien De
Quessada, Julie
Tueur, Giulia
Lefebvre, Christine
Luquet, Isabelle
Toujani, Saloua
Cuccuini, Wendy
Lafage-Pochitaloff, Marina
Michaux, Lucienne
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[6] Cytogenetics in the management of clonal chromosomal abnormalities of undetermined significance and persistent polyclonal B-cell lymphocytosis: Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique H<acute accent>ematologique (GFCH)
Nadal, N.
Auger, N.
Bidet, A.
Nguyen-Khac, F.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[7] Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytog<acute accent>en<acute accent>etique Hematologique (GFCH)
Lefebvre, C.
Veronese, L.
Nadal, N.
Gaillard, J. -b.
Penther, D.
Daudignon, A.
Chauzeix, J.
Nguyen-Khac, F.
Chapiro, E.
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[8] Cytogenetics in the management of acute myeloid leukemia: an update by the Groupe francophone de cytogenetique hematologique (GFCH)
Luquet, Isabelle
Bidet, Audrey
Cuccuini, Wendy
Lafage-Pochitaloff, Marina
Mozziconacci, Marie-Joelle
Terre, Christine
ANNALES DE BIOLOGIE CLINIQUE, 2016, 74 (05) : 535 - 546
[9] Cytogenetics in the management of B-cell acute lymphoblastic leukemia: Guidelines from the Groupe Francophone de Cytogenetique Hematologique (GFCH)
Tueur, Giulia
Quessada, Julie
De Bie, Jolien
Cuccuini, Wendy
Toujani, Saloua
Lefebvre, Christine
Luquet, Isabelle
Michaux, Lucienne
Lafage-Pochitaloff, Marina
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (04)
[10] Banking on innovation: Listed and non-listed equity investing, evidence from soci<acute accent>et<acute accent>e g<acute accent>en<acute accent>erale de Belgique, 1850-1934
Verdickt, Gertjan
Deloof, Marc
EXPLORATIONS IN ECONOMIC HISTORY, 2024, 93

← 1 2 →